Lexeo Therapeutics issues $3 million of unregistered shares in Mantle merger
Lexeo said it issued $3 million of common stock in an unregistered sale tied to its merger with Mantle, with an upfront $5.3 million cash component subject to adjustments.
Lexeo said it issued $3 million of common stock in an unregistered sale tied to its merger with Mantle, with an upfront $5.3 million cash component subject to adjustments.